Vivakor delays Q2 2026 report, sees smaller loss
Vivakor, Inc. notified investors that it will file its Quarterly Report on Form 10-Q for the period ended June 30, 2026 later than the prescribed due date for smaller reporting companies of August 14, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Vivakor, Inc. notified investors that it will file its Quarterly Report on Form 10-Q for the period ended June 30, 2026 later than the prescribed due date for smaller reporting companies of August 14, 2026. The company cites delays in completing its financial statements and related disclosures and is still compiling information and reviewing the financial statements for inclusion in the report. Vivakor anticipates filing the report within the five-day extension period permitted under Rule 12b-25, but explicitly notes there can be no assurance it will meet that timeframe. The company expects results for the quarter to differ significantly from the prior-year period, with higher total revenues and gross profit, lower operating expenses driven by reduced depreciation and amortization, and a reduced net loss attributable to Vivakor, Inc., also affected by changes in interest expense and unrealized gains and losses on marketable securities.
Positive
- Expected operating improvement: Vivakor anticipates higher total revenues and gross profit, lower operating expenses, and a smaller net loss for the quarter ended June 30, 2026 compared with the same period in 2025.
Negative
- Late quarterly filing: The Form 10-Q for June 30, 2026 was not filed by the August 14, 2026 due date, and management states there is no assurance it will be filed within the five-day extension.
Insights
Analyzing...
Key Figures
Key Terms
Rule 12b-25 regulatory
smaller reporting companies regulatory
unrealized gains and losses on marketable securities financial
net loss attributable to Vivakor, Inc. financial
operating expenses financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Why did Vivakor (VIVK) file a Form 12b-25 for its Q2 2026 report?
When does Vivakor (VIVK) expect to file its Form 10-Q for June 30, 2026?
How are Vivakor’s (VIVK) Q2 2026 revenues expected to compare with Q2 2025?
What changes in expenses does Vivakor (VIVK) expect for Q2 2026?
How is Vivakor’s (VIVK) net loss expected to change for Q2 2026?
Does Vivakor (VIVK) indicate all other required reports have been filed?
AI-generated analysis. How Rhea-AI works. Not financial advice.